Tema Cardiovascular and Metabolics ETF Rating $29.53 -0.75 (-2.48%) As of 03/10/2025 03:58 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestTrends Tema Cardiovascular and Metabolics ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HRTS Aggregate RatingModerate Buy 2.80Holdings in HRTS have an aggregate rating of Moderate Buy based on 627 analyst ratings issued in the past year covering 37 companies (82.8% of the portfolio).HRTS Aggregate Price Target$29.53High Prediction$29.53Average Prediction$29.53Low Prediction$29.53Holdings in HRTS have an aggregate price target of $29.53 and a range of $29.53 to $29.53 covering 37 companies (82.8% of the portfolio).HRTS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy25 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Cardiovascular and Metabolics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 37 HRTS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings10.66%LLYEli Lilly and Company$828.80-4.7%4.5214 of 5 stars2.85$1,009.72 21.8%20Positive News5.23%UNHUnitedHealth Group$479.14-2.9%4.9846 of 5 stars3.05$629.32 31.3%22Analyst RevisionPositive News3.95%BBIOBridgeBio Pharma$31.40-0.5%4.4962 of 5 stars2.92$51.55 64.2%123.79%ABTAbbott Laboratories$137.43+0.2%4.8608 of 5 stars2.84$137.94 0.4%19Analyst ForecastPositive News3.72%RHHBYRoche$43.06-1.9%N/A2.5063.61%VRTXVertex Pharmaceuticals$500.01+2.4%3.8505 of 5 stars2.65$506.70 1.3%26Positive News3.34%MRKMerck & Co., Inc.$95.13+0.5%4.9949 of 5 stars2.65$117.12 23.1%23High Trading Volume3.09%TMOThermo Fisher Scientific$526.32-1.0%4.7422 of 5 stars2.82$653.23 24.1%22Positive News2.96%MDTMedtronic$93.75-0.8%4.565 of 5 stars2.44$96.07 2.5%16Dividend AnnouncementPositive News2.93%BSXBoston Scientific$93.79-5.4%4.5464 of 5 stars3.00$108.91 16.1%23Analyst DowngradePositive NewsHigh Trading Volume2.73%GILDGilead Sciences$117.21-0.2%4.6543 of 5 stars2.72$104.24 -11.1%29Positive News2.70%AMGNAmgen$327.36+0.8%4.0837 of 5 stars2.46$314.04 -4.1%24Dividend AnnouncementAnalyst RevisionPositive News2.52%ABBVAbbVie$216.62+1.1%4.4736 of 5 stars2.88$211.45 -2.4%24Positive NewsGap Down2.18%CRNXCrinetics Pharmaceuticals$33.75+1.4%4.2266 of 5 stars2.92$72.64 115.2%13Positive News1.96%DHRDanaher$205.02-3.3%4.9275 of 5 stars2.71$278.00 35.6%21Positive News1.93%CYTKCytokinetics$43.31-0.3%3.8831 of 5 stars2.94$82.00 89.3%181.93%BMYBristol-Myers Squibb$63.00+3.1%4.4815 of 5 stars2.32$57.86 -8.2%19Positive News1.90%REGNRegeneron Pharmaceuticals$744.83+5.3%4.6896 of 5 stars2.76$973.13 30.7%25High Trading Volume1.89%EWEdwards Lifesciences$68.49-2.6%4.6902 of 5 stars2.42$79.95 16.7%26Insider TradePositive News1.83%DXCMDexCom$70.72-9.1%4.9143 of 5 stars2.94$99.82 41.2%18Analyst ForecastGap DownHigh Trading Volume1.76%PODDInsulet$237.06-5.9%4.7401 of 5 stars2.82$292.06 23.2%17High Trading Volume1.70%ALNYAlnylam Pharmaceuticals$233.07-4.7%4.595 of 5 stars2.72$304.26 30.5%25Analyst RevisionPositive News1.56%MCKMcKesson$659.53+2.4%4.4595 of 5 stars2.93$645.79 -2.1%15Positive NewsHigh Trading Volume1.49%ASNDAscendis Pharma A/S$138.18-5.2%3.0031 of 5 stars2.93$202.36 46.4%141.35%MASIMasimo$165.45-5.2%3.3441 of 5 stars2.83$194.80 17.7%61.22%MDGLMadrigal Pharmaceuticals$329.16-0.7%4.0685 of 5 stars2.85$375.75 14.2%13Gap Down1.00%MREOMereo BioPharma Group$2.45-1.6%2.0632 of 5 stars3.43$7.83 219.7%7Positive News0.90%ARWRArrowhead Pharmaceuticals$15.21-10.4%3.7784 of 5 stars2.60$41.44 172.5%10Gap Down0.90%AKROAkero Therapeutics$41.68-1.0%3.9944 of 5 stars3.00$76.29 83.0%9Gap Down0.90%INSMInsmed$73.07-2.4%4.2761 of 5 stars3.00$93.33 27.7%160.88%RCKTRocket Pharmaceuticals$8.59-2.1%4.5892 of 5 stars2.91$42.30 392.4%110.86%MIRMMirum Pharmaceuticals$43.01-1.0%4.1242 of 5 stars3.09$58.20 35.3%11Positive News0.84%IONSIonis Pharmaceuticals$32.22-4.7%4.3598 of 5 stars2.70$60.00 86.2%200.82%GPCRStructure Therapeutics$20.16-10.9%2.7176 of 5 stars3.00$81.29 303.2%80.81%WSTWest Pharmaceutical Services$226.04-2.3%4.9421 of 5 stars2.83$344.00 52.2%6Analyst Revision0.63%VKTXViking Therapeutics$27.96-3.9%4.2246 of 5 stars3.00$96.31 244.4%140.33%NTLAIntellia Therapeutics$9.46-8.6%4.4792 of 5 stars2.63$37.56 297.0%19Gap Down This page (NASDAQ:HRTS) was last updated on 3/11/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Cardiovascular and Metabolics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Cardiovascular and Metabolics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HRTS Stock Alerts